Dataset from A Randomized, Open-label, Two-way Crossover Study to Compare Patient Acceptability/Preference of Tiotropium Respimat® With Tiotropium Handihaler® in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009754
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this study is to investigate the patient acceptability/preference of
Respimat® compared with Handihaler® in patients with moderate to very severe chronic
obstructive pulmonary disease (COPD) to demonstrate the superiority of Respimat®.
创建时间：
2024-11-26
